Clik here to view.
Judge lifts bail, travel restrictions on ex-Acclarent execs
Facteau (l) and Fabian A federal judge in Boston this week lifted the bail and travel restrictions imposed on a pair of former Acclarent executives who were acquitted of felony fraud charges in July....
View ArticleClik here to view.
Alere airs dirty laundry in Abbott lawsuit
Abbott (NYSE:ABT) is deliberately stalling with federal anti-trust regulators, hoping to snuff the pending, $5.8 billion buyout of Alere (NYSE:ALR), according to a lawsuit unveiled this week in a...
View ArticleClik here to view.
FDA approves Medtronic’s Enlite continuous glucose sensor
Medtronic (NYSE:MDT) said today that the FDA approved its Enlite sensor for the iPro2 Professional continuous glucose monitor. Medtronic said the Enlite device, a disposable sensor designed to be worn...
View ArticleClik here to view.
Pivotal trial pits St. Jude Medical’s Amplatzer Amulet anti-stroke device...
St. Jude Medical (NYSE:STJ) said today that it launched a U.S. pivotal trial for its Amplatzer Amulet cardiac implant, which is designed to reduce the risk of stroke in patients with atrial...
View ArticleClik here to view.
Stryker acquires Ivy Sports Medicine and its meniscus repair device
Stryker (NYSE:SYK) said today that its endoscopy division acquired Ivy Sports Medicine and its collagen meniscus implant for an undisclosed amount. Kalamazoo, Mich.-based Stryker touted the Ivy Sports...
View ArticleClik here to view.
Deaths prompt FDA warning on Baxter’s Vascu-Guard patch
Updated to clarify the recent notice did not relate to a recall initiated in June 2015. The FDA today released a notice warning of issues with Baxter‘s (NYSE:BAX) Vascu-Guard peripheral vascular patch...
View ArticleClik here to view.
Boehringer Ingelheim, Qualcomm team on connected inhaler
Boehringer Ingelheim Pharmaceuticals and Qualcomm (NSDQ:QCOM) subsidiary Qualcomm Life yesterday said they’re partnering to create an inhaler that can track user information, hoping to improve outcomes...
View ArticleClik here to view.
Micrima brings in $3.4m for breast imaging tech
Micrima said today it raised $3.4 million (UK £2.6 million) in a new round of financing to support its Maria breast imaging system, with commercialization slated for the end of the year. Micrima’s...
View ArticleClik here to view.
Site selection – What to look for?
Selecting clinical sites for research purposes may be a difficult and seemingly overwhelming task for a sponsor. Familiarity with a site might help with selection, but multiple contributing factors can...
View ArticleClik here to view.
Braun lands FDA nod for Xevonta dialyzer
B. Braun Medical said today it won FDA 510(k) clearance for its xevonta dialyzer and that it is launching the next-generation filter in the U.S. Get the full story at our sister site, Medical Design...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 1, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Proton therapy demand wave drives expansion of Belgium’s IBA
(Reuters) – When Yves Jongen stood at the controls of his proton therapy machine 15 years ago to treat a cancer patient for the first time he was petrified. Now Jongen’s company IBA is hiring 400...
View ArticleClik here to view.
Novo Nordisk CEO Sorenson steps down | Personnel Moves Sept 1, 2016
Novo Nordisk CEO Sorenson steps down Novo Nordisk (NYSE:NVO) said today its current prez and chief exec Lars Sorenson will retire from his position at the end of the year, with current corp dev head...
View ArticleClik here to view.
Navigant buys Dymedex Consulting
Navigant today said it is buying data-driven market analysis consulting firm Dymedex Consulting for an undisclosed amount. Get the full story at our sister site, Medical Design & Outsourcing. The...
View ArticleClik here to view.
Bonesupport touts high infection eradication rate in prospective trial
Bonesupport today released data from the prospective trial of its Cerament G injectable antibiotic-eluting bone substitute, touting a 96% infection eradication rate in patients treated with the...
View ArticleClik here to view.
Study leads to insulin injection recommendations
(Reuters) – Many people who inject themselves with insulin to control diabetes are improperly performing this vital task, according to a large new study. Based on the results, experts have crafted...
View ArticleClik here to view.
Study: Respicardia neurostim implant shows promise in treating central sleep...
An implanted neurostimulator developed by Respicardia has been shown to significantly improve symptoms of central sleep apnea without serious side effects, according to a new study from the Ohio State...
View ArticleClik here to view.
Parexel shares slide on embezzlement news
Parexel saw shares drop 4.3% after releasing information on the embezzlement of corporate funds at one of the company’s international operations in an SEC filing. Get the full story at our sister site,...
View ArticleClik here to view.
Seeing inside: Beta cell transplants to treat diabetes
Type 1 diabetes afflicts more than 300 million people worldwide. Researchers have long sought a way to replace the insulin-producing beta cells lost in the disease, but transplanted cells are...
View ArticleClik here to view.
Nestlé’s health science unit inks staged acquisition of Phagesis
The health science business owned by Nestlé (VTX:NESN) said yesterday that it agreed to a staged acquisition of Phagenesis and its device for treating patients who can’t swallow. The deal calls for an...
View Article